Company Overview and News

 
SSL Selected to Provide Powerful All-Electric Satellite to Eutelsat

2016-03-22 asdnews
Space Systems Loral (SSL), a leading provider of commercial satellites, today announced that it was selected to provide a high power all-electric satellite to Eutelsat, one of the world's leading satellite operators. The satellite will principally provide broadcast services to multiple regions including Africa, the Middle East, and Turkey.

 
SSL selected to provide powerful all-electric satellite to Eutelsat

2016-03-22 prnewswire
PALO ALTO, CA, March 21, 2016 /PRNewswire/ - Space Systems Loral (SSL), a leading provider of commercial satellites, today announced that it was selected to provide a high power all-electric satellite to Eutelsat, one of the world's leading satellite operators. The satellite will principally provide broadcast services to multiple regions including Africa, the Middle East, and Turkey.

 
The Eutelsat satellite for Arianespace's next mission comes to French Guiana

2016-02-10 asdnews
Transported aboard a chartered Antonov An-124 cargo airliner that touched down at Félix Eboué Airport near the capital city of Cayenne on Friday, the SSL-built (Space Systems Loral) satellite was then transferred via road to the Spaceport’s payload preparation facilities.

 
Eutelsat and ViaSat Forming JV to Expand Satellite Broadband in Europe

2016-02-10 asdnews
New Partnership Will Leverage Eutelsat's Successful European Broadband Business and ViaSat's Advanced Broadband Technologies and Consumer ISP Business Expertise

 
SSL delivers Eutelsat's advanced Latin America satellite to launch base

2016-02-08 prnewswire
PALO ALTO, CA, Feb. 8, 2016 /PRNewswire/ - Space Systems Loral (SSL), a leading provider of commercial satellites,...

 
ILS Proton Successfully Launches the Eutelsat 9b Satellite

2016-02-01 asdnews
International Launch Services (ILS) successfully placed the EUTELSAT 9B satellite into geosynchronous transfer orbit today, for Eutelsat Communications of Paris, France. With this mission, ILS, a leader in providing mission integration and launch services to the global commercial satellite industry, completed its 92nd Proton launch overall and 1st Proton launch of 2016. Since its maiden flight in 1965, this was the 410th aggregate launch for the Proton vehicle, including both Federal and commercial missions.

 
ILS Proton with the Eutelsat 9B Spacecraft Rolls out to Launch Pad 39

2016-01-27 asdnews
You are here: ASDNews Home > ILS Proton with the Eutelsat 9B Spacecraft Rolls out to Launch Pad 39

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...